Amundi Asset Management US’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-123,900
| Closed | -$1.96M | – | 1630 |
|
|
2018
Q2 | $1.96M | Buy |
+123,900
| New | +$1.96M | ﹤0.01% | 1123 |
|
|
2017
Q3 | – | Sell |
-467,813
| Closed | -$5.36M | – | 533 |
|
|
2017
Q2 | $5.36M | Sell |
467,813
-316,076
| -40% | -$3.62M | 0.02% | 393 |
|
|
2017
Q1 | $16.3M | Sell |
783,889
-20,996
| -3% | -$437K | 0.05% | 230 |
|
|
2016
Q4 | $16.7M | Sell |
804,885
-130,556
| -14% | -$2.72M | 0.06% | 234 |
|
|
2016
Q3 | $30.7M | Buy |
935,441
+110,453
| +13% | +$3.62M | 0.11% | 157 |
|
|
2016
Q2 | $20.6M | Buy |
824,988
+402,270
| +95% | +$10M | 0.07% | 205 |
|
|
2016
Q1 | $10.4M | Sell |
422,718
-154,296
| -27% | -$3.78M | 0.04% | 288 |
|
|
2015
Q4 | $19.1M | Sell |
577,014
-405,093
| -41% | -$13.4M | 0.07% | 227 |
|
|
2015
Q3 | $32.2M | Buy |
982,107
+47,330
| +5% | +$1.55M | 0.13% | 159 |
|
|
2015
Q2 | $49.5M | Buy |
+934,777
| New | +$49.5M | 0.18% | 148 |
|